The latest findings, while still preliminary, suggest that GLP-1s may play a role in improving pregnancy outcomes by helping women better manage their weight and blood sugar, the researchers wrote
Z., Friedlander, N., Qiu, Y., & Leslie, R
KFF reports that policymakers and insurers are increasingly evaluating strategies to manage the financial impact of GLP-1 coverage, particularly within Medicare and Medicaid programs where long-term costs could become significant
Cancellation stops future charges
Furthermore, survodutide at doses of 1.8 mg or higher resulted in more substantial weight loss than semaglutide 1.0 mg after the same treatment period
Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, et al